Gamunex-C (intravenous immunoglobulin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gamunex-C (intravenous immunoglobulin), covering 2016-08-05 to 2016-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions [Phase 1]